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Four strains of Butyrivibrio ﬁbrisolvens, transformed with a gene encoding ﬂuoroacetate dehalogenase,
maintained a combined population of 10
6 to 10
7 cells ml
21 in the rumens of test sheep. Five inoculated sheep
showed markedly reduced toxicological symptoms after ﬂuoroacetate poisoning when behavioral, physiological,
and histological effects were compared with those of ﬁve uninoculated control sheep.
Monoﬂuoroacetate occurs in some Australian plants at lev-
e l so fu pt o5gk g(dry weight)
21 (8) and has a 50% lethal dose
in ruminants of around 0.3 mg kg of body weight
21 (2). The
toxin appears to be cumulative, and a series of sublethal doses
can result in fatal poisoning (2). It is not surprising, therefore,
that loss of livestock from ﬂuoroacetate poisoning is econom-
ically signiﬁcant (12). The work described here is part of a
project to develop genetically modiﬁed ruminal bacteria that
will provide protection against ﬂuoroacetate poisoning.
Three Butyrivibrio ﬁbrisolvens strains, OB156, OB291, and
10/1, were transformed with plasmid pBHf by electroporation
(3, 7) and expressed ﬂuoroacetate dehalogenase activity at 10
nmol of ﬂuoride released min
21 mg of bacterial protein
21 (7).
Strain OR85 expressed dehalogenase activity at (20 6 1.7) nmol
min
21 mg
21 when transformed with a pBHf derivative with
four base pairs removed from between the putative 210 and
235 regions of the gene promoter (pBHf
24) (unpublished
data). OB156, OB291, and OR85 were supplied by R. Forster
and R. M. Teather (4) (CFAR, Agriculture and Agrifood Can-
ada, Ottawa, Ontario, Canada). B. ﬁbrisolvens 10/1 was isolated
from sheep (11) at the Institute of Biotechnology (University
of New England, Armidale, New South Wales, Australia).
Recombinant bacteria were grown in ruminal ﬂuid medium
(10) containing yeast extract in place of peptone. Erythromycin
was added (50 mgm l
21) except in subcultures prepared for
inoculation into the rumen. In previous observations (5, 6), the
population of individual bacterial strains within the rumen
ﬂuctuated within the range ,10
3 to 10
7 cells ml
21. Therefore,
a combination of four modiﬁed strains was used to ensure that
effective numbers of detoxifying bacteria would be present
consistently. Fifty-milliliter stationary-phase cultures of each
strain (10
8 to 10
9 cells ml
21) were pooled, and 60 ml of the
mixture was inoculated into the rumen of each test animal.
Trial I used four Merino/Border-Leicester crossbred sheep,
and trial II used six pure-bred Merino sheep; all sheep were
housed in metabolism crates in a PC2-classiﬁed room. Sheep
received four meals daily (150 g of oat chaff plus 50 g of alfalfa
chaff) between 10 a.m. and 4 p.m. Water was provided ad
libitum.
Sheep rumens were surgically cannulated for removal of
samples. These included particles ,1 mm in diameter. Sam-
ples were heated (95°C for 10 min) to inactivate nucleases and
centrifuged (12,000 3 g for 90 s), and the supernatant was
removed. The pellet was resuspended in water (10 times the
volume of the original sample) and recentrifuged. This proce-
dure was repeated once, and the ﬁnal pellet was suspended in
10 volumes of water. Dilutions of 10
22,1 0
23,1 0
24, and 10
25
were prepared and tested by PCR for the presence of dehalo-
genase gene sequences (1).
PCR primers used for dehalogenase gene detection were
CC5 (59-TGCGAGGCTATGGCGATTCGGACA-39) and
CC6.2i (59-CTGACCGATCATGTGCTCGGGGAA-39),
both of which ampliﬁed a 322-bp fragment from the coding
region of the dehalogenase gene (9). PCR conditions were as
follows: 2 cycles of 95°C for 5 min, 55°C for 40 s, and 72°C for
60 s followed by 28 cycles of 95°C for 60 s, 55°C for 40 s, and
72°C for 60 s. Tests on ruminal samples to which transformed
bacteria had been added showed that pBHf was detectable in
the presence of a single target bacterium. Inclusion of 1 mlo f
sample in the PCR mixture allowed a threshold of detection of
10
3 cells ml
21. Detection of the plasmid at a dilution of 10
24
(for example) indicated a ruminal population of $10
7 cells
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FIG. 1. Agarose gel with PCR products from 10-fold serial dilutions of ru-
minal particles from sheep T1 (trial I). Lanes and fold dilutions of ruminal
samples are as follows: A, 10
21;B ,1 0
22;C ,1 0
23;D ,1 0
24;E ,1 0
25. Aliquots of
1 ml were used in each reaction. Lane F is the positive control product, and lane
G contains l HindIII size markers. The diffuse lower band was a commonly
observed artifact in PCR that used complex biological mixtures as a source of
template.
3496ml
21 in the original sample (Fig. 1). Preinoculation ruminal
samples yielded no dehalogenase gene PCR products and were
routinely used as negative controls.
Fluoroacetate solution was injected into snow peas or ab-
sorbed into feed pellets or alfalfa biscuits. These were usually
eaten voluntarily, even when chaff was refused. The biscuits
were '0.5 g each and were made from alfalfa which had been
blended to a coarse slurry with a 10% sucrose solution, pressed
into discs to remove most of the ﬂuid, and dried overnight at
60°C. On the three occasions that control sheep 2 (C2) (trial
II) refused to eat them, the biscuits were placed into the ru-
mens of both C2 and test sheep 2 (T2) via the cannula. Con-
tinuous assessments were made of feeding, drinking, response
to external stimuli, stance, movement, and sleeping behavior.
In trial II, heart rates were measured with an electrocardio-
graph.
In trial I, sheep were challenged with ﬂuoroacetate 10 days
after inoculation (Table 1), when the modiﬁed strains had
established a stable combined population of .10
7 cells ml
21 in
T1 and .10
6 cells ml
21 in T2. In trial II, the recombinant
bacteria were allowed ﬁve weeks to stabilize their population
to .10
6 cells ml
21 in all three sheep before challenge with
ﬂuoroacetate. Recombinant bacteria were undetectable in
control sheep.
Trial I. At a cumulative dose of 0.255 mg of ﬂuoroacetate
kg
21, control sheep exhibited alarm at familiar noises, com-
pulsive agitated feeding, periodic muscle spasms, “paddling”
movements of the legs, skin ﬂushing, panting, and frequent
attempts to escape from their crates by jumping. Inoculated
test sheep showed occasional head twitching and rapid breath-
ing and periodically increased alertness but remained calm,
eating and drinking normally.
At 0.492 mg of ﬂuoroacetate kg
21, control sheep showed
intensiﬁcation of all symptoms and died. Behavior of both test
sheep remained unchanged. T2 displayed no signs of acute
toxicity but, four hours after the death of the control sheep,
died of pulmonary edema, which is common in chronic ﬂuoro-
acetate poisoning (3a). Sheep T1 survived the test.
Trial II. At 0.255 mg of ﬂuoroacetate kg
21, control sheep
became lethargic and refused food and water. Hyperexcitabil-
FIG. 2. Heart rate measurements from sheep in trial II commencing 12 h
after the ﬁrst dose of ﬂuoroacetate in the series (Table 1). Heart rates measured
for these sheep the day before dosing were in the range of 60 to 80 beats min
21.
The three lines (from the front to the back of the three-dimensional diagram)
represent measurements from sheep T1 to T3 and C1 to C3, respectively.
TABLE 1. Fluoroacetate dosage schedule for toxicity trials I and II
Toxicity
trial
Time
period
Dose
every:
Dose increment(s),
mg kg
21
Accumulated
dose, mg kg
21
I 0–10 h 2 h 1 3 0.045, 5 3 0.03 0.195
20–22 h 2 h 2 3 0.03 0.255
45–57 h 6 h 2 3 0.015, 1 3 0.012 0.297
140–152 h 1 h 13 3 0.015 0.492
II 0–12 h 2 h 6 3 0.03, 1 3 0.015 0.195
22–24 h 2 h 2 3 0.03 0.255
38–42 h 2 h 3 3 0.015 0.300
46 h NA 1 3 0.03 0.330
a NA, not applicable.
TABLE 2. Pathological and histological observations
Tissue and feature
Result for sheep:
C1 C2 C3 T1 T2 T3
Liver
Color Dark Dark Dark Normal Normal Normal
Congestion Marked Marked Marked Mild Mild Moderate
Mononuclear cell inﬁltration None Mild Mild Very mild None None
Lungs
Congestion Moderate Severe Moderate Mild Mild Severe
Texture Consolidated ﬁrm Consolidated ﬁrm Normal Normal Normal Normal
Atelectasia and focal emphysema Mild Mild None None None None
Perivascular mononuclear cell inﬁltrate Mild Mild None None None None
Kidneys
Color Dark Dark Dark Normal Normal Normal
Protein inclusions: proximal tubules Present None Present None None None
Heart (multifocal mononuclear cell inﬁltration) Mild/moderate Mild/moderate Moderate/focally severe None Very mild Very mild
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was evident from their faltering stance. Test sheep showed no
toxicity symptoms.
At 0.33 mg of ﬂuoroacetate kg
21, control sheep continued to
refuse food and remained lethargic, with pronounced unsteadi-
ness when standing. Electrocardiograms showed heart rates
rising to 140 to 200 beats min
21. Test sheep reduced their feed
intake approximately 30% but otherwise behaved normally,
with maximum heart rates of 80 to 100 beats min
21 (T3 only
[Fig. 2]). Prior to administration of ﬂuoroacetate, heart rates of
all sheep were in the range of 60 to 80 beats min
21. All sheep
survived trial II.
Control sheep displayed reduced appetite to day 6, contin-
ued unsteadiness on standing up to day 5, and involuntary
muscle activity (head twitching) through day 4. T1 and T2
returned to normal eating habits by day 4, and T3 continued to
eat approximately 30% less than usual up to day 6. In all other
respects, test sheep remained asymptomatic.
Trial II sheep were euthanized with pentobarbitone (Letho-
barb), and necropsies were performed by Rob Woodgate and
Bruce Chick of the Veterinary Health Research Laboratory,
Armidale, New South Wales, Australia. Tissue samples were
ﬁxed in 10% formaldehyde for histological examination (S.
Hum, Regional Veterinary Laboratory, Menangle, New South
Wales, Australia). The control sheep displayed measurably
greater tissue damage (Table 2).
The intraruminal levels of modiﬁed bacteria achieved here
allowed us to demonstrate their protective effect upon host
animals, but an increased level of protection would be desir-
able for ﬁeld trials with larger numbers of animals. This would
require additional recombinant strains in the rumen and/or
more efﬁcient expression of dehalogenase from each strain.
Current work is aimed to achieve these improvements.
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